Healthpeak Properties (NYSE: DOC) insider transactions
In the twelve months to 10 November 2026, executives and directors of Healthpeak Properties reported 2 open-market sales of 17,104 shares ($340,806) and 0 open-market purchases, by 2 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 9 November 2026 | Patadia Ankit B. | EVP and Treasurer | Open-market sale | −6,115 | $20.78 | 2,838 | Form 4 |
| 5 November 2026 | Lewis Sara Grootwassink | Director | Other | −46,744 | — | 9,744 | Form 4 |
| 5 November 2026 | Lewis Sara Grootwassink | Director | Other | +46,744 | — | 68,744 | Form 4 |
| 29 May 2026 | Thomas John T | Director | Grant or award | +1,385 | $15.46 | 830,053 | Form 4 |
| 29 May 2026 | Thomas John T | Director | Shares withheld for tax | −78 | $19.15 | 829,975 | Form 4 |
| 29 May 2026 | Brinker Scott M | President and CEO | Grant or award | +1,347 | $15.46 | 214,802 | Form 4 |
| 29 May 2026 | Brinker Scott M | President and CEO | Shares withheld for tax | −114 | $19.15 | 214,688 | Form 4 |
| 29 May 2026 | Johnston Shawn G | EVP and CAO | Grant or award | +1,358 | $15.46 | 42,336 | Form 4 |
| 29 May 2026 | Johnston Shawn G | EVP and CAO | Shares withheld for tax | −76 | $19.15 | 42,260 | Form 4 |
| 29 May 2026 | Mabry Adam G | CIO | Grant or award | +625 | $15.46 | 5,140 | Form 4 |
| 29 May 2026 | Mabry Adam G | CIO | Shares withheld for tax | −43 | $19.15 | 5,097 | Form 4 |
| 29 May 2026 | Patadia Ankit B. | EVP and Treasurer | Grant or award | +1,358 | $15.46 | 9,047 | Form 4 |
| 29 May 2026 | Patadia Ankit B. | EVP and Treasurer | Shares withheld for tax | −94 | $19.15 | 8,953 | Form 4 |
| 29 May 2026 | Moses Kelvin O | Chief Financial Officer | Grant or award | +937 | $15.46 | 1,692 | Form 4 |
| 29 May 2026 | Moses Kelvin O | Chief Financial Officer | Shares withheld for tax | −65 | $19.15 | 1,627 | Form 4 |
| 12 May 2026 | Bohn Scott R | CDO and Head of Lab | Open-market sale | −10,989 | $19.45 | 7,636 | Form 4 |
| 6 May 2026 | Lewis Sara Grootwassink | Director | Grant or award | +9,744 | — | 56,488 | Form 4 |
| 6 May 2026 | Griffin R Kent Jr | Director | Grant or award | +9,744 | — | 90,195 | Form 4 |
| 6 May 2026 | Connor James B. | Director | Grant or award | +9,744 | — | 38,169 | Form 4 |
| 6 May 2026 | Weiss Richard A. | Director | Grant or award | +9,744 | — | 79,469 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Healthpeak Properties page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.